Strategies to counteract these tumour-promoting activities involve depleting or repolarising myeloid cells to restore efficient activity of anti-tumour effector immune cells such as NK cells, Th1 CD4+ T lymphocytes and CD8+ cytotoxic T lymphocytes, as well as their infiltration into the malignant tissue.76 This evidence concerns the gene CD8A and neoplasm.